Trials / Completed
CompletedNCT04107051
Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence
Nalmefene Hydrochloride Hydrate Tablets 10mg Specified Drug-use Results Survey (the Safety and the Prognosis After Achieving Reduced Alcohol Intake)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 533 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and the prognosis after achieving reduced alcohol intake in patients with alcohol dependence who received treatment for the reduction of alcohol intake in the routine clinical setting in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nalmefene Hydrochloride Hydrate | Oral administration of nalmefene hydrochloride hydrate |
Timeline
- Start date
- 2019-10-01
- Primary completion
- 2023-02-07
- Completion
- 2024-02-06
- First posted
- 2019-09-27
- Last updated
- 2025-03-21
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04107051. Inclusion in this directory is not an endorsement.